SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012240
Filing Date
2022-08-04
Accepted
2022-08-04 16:31:56
Documents
51
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gbio-20220630x10q.htm   iXBRL 10-Q 1202798
2 EX-10.1 gbio-20220630xex10d1.htm EX-10.1 10336
3 EX-31.1 gbio-20220630xex31d1.htm EX-31.1 7624
4 EX-31.2 gbio-20220630xex31d2.htm EX-31.2 8141
5 EX-32.1 gbio-20220630xex32d1.htm EX-32.1 5113
6 EX-32.2 gbio-20220630xex32d2.htm EX-32.2 5092
  Complete submission text file 0001558370-22-012240.txt   4030246

Data Files

Seq Description Document Type Size
7 EX-101.SCH gbio-20220630.xsd EX-101.SCH 24616
8 EX-101.CAL gbio-20220630_cal.xml EX-101.CAL 33128
9 EX-101.DEF gbio-20220630_def.xml EX-101.DEF 99328
10 EX-101.LAB gbio-20220630_lab.xml EX-101.LAB 219307
11 EX-101.PRE gbio-20220630_pre.xml EX-101.PRE 188415
45 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20220630x10q_htm.xml XML 555790
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

IRS No.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39319 | Film No.: 221137172
SIC: 2834 Pharmaceutical Preparations